eFFECTOR Therapeutics (EFTR) Stock Chart & Stock Price History $0.0002 0.00 (0.00%) As of 07/23/2025 12:08 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsInsider TradesSEC FilingsShort InterestTrendsBuy This Stock eFFECTOR Therapeutics Stock Price Performance The eFFECTOR Therapeutics (EFTR) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 99.58%, with a year-to-date return of 0.00%. In the past month, the stock has decreased 33.33%, reflecting recent market activity. As of the latest close, eFFECTOR Therapeutics traded at $0.00 with a market cap of $1 thousand and volume of 150 shares. Receive EFTR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for eFFECTOR Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance0.00%1 Month Performance-33.33%3 Month Performance0.00%Year-To-Date Performance0.00%1 Year Performance-99.58% EFTR Stock Chart for Thursday, July, 24, 2025 EFTR Chart by TradingView eFFECTOR Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/24/2025$0.00$0.00$0.00$0.00150 shs$1,000.0007/23/2025$0.00$0.00$0.00$0.00150 shs$1,000.0007/22/2025$0.00$0.00$0.00$0.003,498 shs$1,000.0007/21/2025$0.00$0.00$0.00$0.00741 shs$1,000.0007/18/2025$0.00$0.00$0.00$0.002,055 shs$1,000.0007/17/2025$0.00$0.00$0.00$0.002,055 shs$1,000.0007/15/2025$0.00$0.00$0.00$0.004 shs$1,000.0007/14/2025$0.00$0.00$0.00$0.002,946 shs$1,000.0007/11/2025$0.00$0.00-50.00%$0.00$0.002,946 shs$1,000.0007/10/2025$0.00$0.00+100.00%$0.00$0.00401 shs$2,000.00 Get the Latest News and Ratings for EFTR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for eFFECTOR Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/09/2025$0.00$0.00$0.00$0.001 shs$1,000.0007/08/2025$0.00$0.00$0.00$0.002,017 shs$1,000.0007/07/2025$0.00$0.00$0.00$0.002,017 shs$1,000.0007/04/2025$0.00$0.00$0.00$0.00800 shs$1,000.0007/03/2025$0.00$0.00-33.33%$0.00$0.00800 shs$1,000.0007/02/2025$0.00$0.00$0.00$0.00573 shs$1,000.0007/01/2025$0.00$0.00$0.00$0.00573 shs$1,000.0006/30/2025$0.00$0.00$0.00$0.001 shs$1,000.0006/27/2025$0.00$0.00$0.00$0.001 shs$1,000.0006/26/2025$0.00$0.00$0.00$0.001 shs$1,000.0006/25/2025$0.00$0.00$0.00$0.0020 shs$1,000.0006/24/2025$0.00$0.00$0.00$0.002 shs$1,000.0006/23/2025$0.00$0.00$0.00$0.005,393 shs$1,000.00 Related Companies Ampio Pharmaceuticals Stock Price Chart Histogen Stock Price Chart OncoSec Medical Stock Price Chart PaxMedica Stock Price Chart 180 Life Sciences Stock Price Chart 4D pharma Stock Price Chart Aesther Healthcare Acquisition Stock Price Chart Ainos Stock Price Chart Alvotech Stock Price Chart Atlantic Coastal Acquisition Corp. II Stock Price Chart Receive EFTR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for eFFECTOR Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:EFTR) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredWhy Elon put $51 million into thisA single U.S. company has started producing a “miracle metal” once locked in research labs. Now? They’re qu...True Market Insiders | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding eFFECTOR Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share eFFECTOR Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free EFTR Stock Alerts